Cell Therapy Manufacturing: Operational Strategies for Success

This one-day, in-person, expert-led training is designed for senior lab professionals, including lab managers, lab directors, process development associates, and quality control and quality assurance associates seeking to optimize their cell product manufacturing processes. The course focuses on critical areas within the cell manufacturing workflow where inconsistencies and challenges frequently occur. Participants will benefit from real-world case studies presented by leading academic and industry experts from North America and Europe.

Special bundle pricing for this course is available with ISCT 2026 registration.

Based on past participants who attended the same Training Program
at the ISCT 2025 New Orleans Annual Meeting

95%

Satisfied with the overall learning experience

90%

Would recommend the course to a colleague

93%

Rated the training as highly valuable

Focus on product quality, characterization, and regulatory compliance:

Standardizing processes to ensure cell product quality, with emphasis on cryopreservation and thawing techniques
Product characterization methods for consistent and reliable results
Safety testing procedures to meet regulatory standards

Additionally, this course offers perspectives on regional regulatory expectations and technology adoption trends, fostering a comprehensive understanding of the global landscape.

Interactive Q&A sessions and panel discussions, led by subject matter experts, enable participants to deepen their knowledge, explore regional and international practices, and ask targeted questions tailored to their specific needs.

Standardized Cell Processing: Standardize workflows to protect cell product quality, with a focus on cryopreservation and thawing best practices.
Product Characterization: Apply characterization methods that support consistent, reliable, and interpretable results.
Safety & Regulatory Testing: Identify core safety testing procedures needed to meet regulatory expectations.
Global Regulatory Perspectives: Compare regional regulatory expectations and understand how they influence manufacturing and testing decisions.
Technology Adoption Trends: Recognize key technology adoption trends across regions and how they impact implementation choices.
Expert-Led Application: Strengthen practical understanding through interactive Q&A and panel discussions, using targeted questions relevant to your role and region.

Designed For

Senior laboratory professionals, including technologists, lab managers, directors, process development associates and QA/QC personnel.

Price (USD)

Category	ISCT Member	Non-Member
Lab Technologists / Pharmacist / Nurse Practitioner / Nurse	$260	$385
Students / Resident / Fellow / Postdoc	$125	$245
Academia	$300	$475
Industry	$350	$525
Training Course + ISCT 2026 Annual Meeting
If you are registered for the Full Conference, attend this course for only $90.	$90
Note: If you do not see the correct rates during registration, please email us at workforcedevelopment@isctglobal.org.

For full details on our course policies, including cancellations, complaints and appeals processes, and our privacy policy, click here.

ELIGIBILITY REQUIREMENTS

Experience with cell culture and aseptic techniques
Basic understanding of cell therapy biomanufacturing workflow and cGMP regulations
Foundational knowledge of quality control and testing in cell therapy development

Rates (USD)

Category	ISCT Member	Non-Member
Academia	$5,230	$6,000
Industry	$5,500
Start-Up	$5,400
15% Group Registration Discount available for 5+ Members / Non-Members from the same institution.

Group Registration Discount:

Receive 15% off when registering 5+ ISCT Members / Non-Members from the same company / institution.
Contact ISCT at workforcedevelopment@isctglobal.org to obtain the discounted Group Registration Rate.

Cancellation Policy: Registration cancellation must be made by email to workforcedevelopment@isctglobal.org at least twenty (20) business days before the course start date. A 10% administrative fee is applied to all cancellations. Registration fee is non-refundable if it is cancelled within twenty (20) business days of the course start date.

ISCT reserves the right to cancel the course if we do not receive a minimum number of registrations twenty (20) business days in advance of the start date. Should the course be cancelled, your payment will be refunded in full. We recommend that you purchase travel insurance with your flights to cover the possibility of the course being cancelled.

The Resource Hub provides supporting materials to help reinforce learning before, during, and after the course.

Webinar title placeholder

Resource link placeholder
Resource link placeholder
Resource link placeholder

UPON COMPLETION, YOU WILL RECEIVE:

5 CMLE Credits
CMLE Certificate upon successful completion

Note: Completing all training modules and passing the quizzes is mandatory to receive a course completion certificate.

ACCREDITED BY:

5 CMLE Hours

*Completing all training sessions and passing the assessment is mandatory to receive a course completion certificate.

What Past Participants Are Saying

“Lecture sessions on manufacturing and real-world examples were especially valuable. The concrete case studies helped translate complex regulatory guidance into practical recommendations that I can apply in my work. I also appreciated the discussions around safety testing, risk assessment, and validation, which provided a clearer understanding of how products move from development to clinical use.”

Omar H.

“The course provided strong insights into regulatory considerations and GMP requirements for cell and gene therapy manufacturing. I particularly valued the sessions on facility setup, quality control, and compliance differences between product classifications. The program highlighted both the scientific and operational challenges involved in bringing advanced therapies to patients.”

Kevin P.

“I found the workshop highly informative, especially the discussions on manufacturing workflows, scale-up considerations, and real-world implementation challenges. The interactive case studies and concrete examples helped illustrate how theoretical concepts apply to industry practice. Overall, the training offered meaningful insights into the complexities of translating cell therapy products into clinical settings.”

Hana T.